Erxi Wu, assistant professor of pharmaceutical sciences, recently was invited to present his research at Sanford Research, Sioux Falls, S.D.

During the two-day visit, Wu met one-on-one or in groups with faculty at the Cancer Research Center, Children’s Health Research Center and Cardiovascular Health Research Center at Sanford Research. Wu also presented a seminar titled “Cancer Therapeutics: Target and Drug Discovery.” One example he discussed is platelet-derived growth factor receptors as therapeutics targets in metastatic medulloblastoma and cambogin, a newly discovered platelet-derived growth factor receptors’ inhibitor from his group.

“I am very impressed by Sanford Research’s facilities and accomplishments. I am happy we will establish close collaborations with some of the researchers at Sanford in the near future,” Wu said.

According to its website, Sanford Research is a nonprofit research organization formed between Sanford Health and the University of South Dakota. Sanford Research is composed of several research centers including Cancer Biology, Cardiovascular Health, Health Disparities, Methodology and Data Analysis, Sanford Children’s Health and the Sanford Project. For more information, visit www.sanfordresearch.org.

Wu lab research areas include tumor therapeutic targets, drug target proteins, biomarkers, drug discovery, natural products, Traditional Chinese Medicine/complementary and alternative medicine, and pharmacogenomics. For more information on Wu, visit www.ndsu.edu/pharmsci/faculty_staff/erxi_wu.